Global Drug and Gene Delivery Devices Market
According to Intent Market Research, the Drug and Gene Delivery Devices Market is expected to grow from USD 370.0 billion in 2023 at a CAGR of 10.7% to touch USD 756.0 billion by 2030. The Drug and Gene Delivery Devices Market is dominated by key players such as AbbVie Inc., BD (Becton, Dickinson and Company), Medtronic, Boston Scientific Corporation, Johnson & Johnson, Stryker Corporation, Novartis AG, Pfizer Inc., Roche Holding AG, Novo Nordisk, Mylan N.V., Siemens Healthineers, Merck & Co., Inc., AstraZeneca, Sanofi S.A.